Improved detection of central vein sign in multiple sclerosis using optimized susceptibility weighted imaging at 3 Tesla
OBJECTIVES: The central vein sign (CVS) is a novel diagnostic imaging biomarker that improves differentiation of white matter lesions (WMLs) caused by multiple sclerosis (MS) and radiological mimics. While susceptibility-weighted imaging (SWI) is widely available for visualizing venous structures, standard SWI protocols are not optimized for standalone CVS detection and require T2-FLAIR images to co-localize T2-hyperintense WMLs. This study evaluated whether an optimized SWI protocol improves CVS detection and reader confidence at 3 T. MATERIALS AND METHODS: Seventeen patients with a clinical diagnosis of MS were scanned on a 3 T MRI scanner using a standard SWI and an optimized SWI acquired with a lower flip angle (FA = 5°). Two radiologists, blinded to the SWI imaging protocols, evaluated the presence of CVS and their confidence levels. Subsequent subject-level analysis was performed to assess the positive detection rate for MS using the "Select-6" rule. RESULTS: Optimized SWI detected all CVS+ lesions identified by standard SWI plus 33 additional lesions (105 vs. 72). Optimized SWI detected more CVS+ lesions than standard SWI in 14/17 participants, with a higher median number of CVS+ lesions detected per participant (7.0 vs. 4.0; p < 0.001). Optimized SWI also increased high-confidence CVS+ classification compared with standard SWI (p = 0.006). Positive detection rate for MS using Select-6 increased from 41.2% with standard SWI to 82.4% with optimized SWI (p = 0.016). CONCLUSION: This feasibility study demonstrates that acquiring SWI with a lower FA at 3 T significantly improves CVS detection, reader confidence, and positive detection rate for MS. KEY POINTS: Question Standard SWI can visualize venous structures at 3 T, but provides limited lesion conspicuity, which prevents standalone detection of the central vein sign (CVS). Findings Optimized SWI with a low flip angle detects more CVS-positive lesions, increases high-confidence CVS classification, and improves MS detection rate using the Select-6 rule. Clinical relevance Optimized SWI improves CVS visibility and rater confidence without increasing scan time, providing a simple technical optimization for assessment of CVS at 3 T.
Authors
- M. Marcel Maya (ORCID: https://orcid.org/0000-0003-4097-8639)
- Nader Binesh
- Daniel Ontaneda (ORCID: https://orcid.org/0000-0002-2838-9148)
- Michael Luu
- Omar Al‐Louzi (ORCID: https://orcid.org/0000-0003-2260-5660)
- Yin-Chen Hsu (ORCID: https://orcid.org/0000-0003-4483-486X)
- Angel Liu (ORCID: https://orcid.org/0009-0008-9454-4928)
- Nancy L. Sicotte (ORCID: https://orcid.org/0000-0002-5131-3352)
- Pascal Sati (ORCID: https://orcid.org/0000-0002-6763-0125)
- Marwa Kaisey (ORCID: https://orcid.org/0000-0001-6019-7317)
- Debiao Li (ORCID: https://orcid.org/0000-0001-8560-8231)
- Sreekanth Madhusoodhanan Nair (ORCID: https://orcid.org/0000-0003-3549-3848)
- Elaina Luskin (ORCID: https://orcid.org/0009-0008-6482-737X)
- Abdul Jaber Tayem (ORCID: https://orcid.org/0009-0007-4431-7682)
- Diana Ayrapetyan
- Yibin Xie
- Lixia Wang
Institutions
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
Publication Details
- Journal
- European Radiology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s00330-026-13069-3
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Cedars-Sinai Medical Center
- National Institute of Neurological Disorders and Stroke